Stryker (SYK) Gains 11.6% YTD: What's Driving the Stock?
Styker's (SYK) flagship Mako Total Knee Platform and a diversified product portfolio raise optimism about the stock.
Reasons to Retain Stryker (SYK) Stock in Your Portfolio Now
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform Mako and its broad product portfolio.
Stryker's (SYK) LIFEPAK 35 to Offer Advanced Monitoring System
Stryker (SYK) announces the launch of LIFEPAK 35 monitor/defibrillator, which is likely to aid emergency responders to reduce cognitive load during demanding situations by improving workflow.
Stryker's (SYK) Acquisition of Artelon Set to Expand Its Market
Stryker (SYK) announces the signing of the definitive agreement to acquire a privately held company, Artelon, to strengthen its foothold in the soft tissue fixation market.
Stryker (SYK) to Launch Gamma4 Hip Fracture System in Europe
Stryker (SYK) announces plan to launch its Gamma4 Hip Fracture Nailing System in Europe. It completes initial surgeries successfully.
Stryker (SYK) Issues Safety Notice for Its Total Knee System
Stryker (SYK) issues urgent field safety notice for the Mako Total Knee systems, the application software of which generated software error codes. The company also shares risk mitigation steps.
